Daily non-political popular news in brief.

Pancreatic cancer vaccine halts progression of disease in some patients

A dendritic cell-based therapeutic vaccine for pancreatic cancer developed by researchers at the University of Pittsburgh School of Medicine has successfully stalled the disease from progressing in a handful of patients three years post-vaccination. The results, part of a press briefing on cancer vaccines held at the annual meeting of the American Association of Cancer Research, provide promising evidence that the vaccine can trigger a patient's own immune system to rally against pancreatic cancer.

Read more »

Keywords: pancreatic, cancer, vaccine, halts, progression, disease, patients, halt, patient

« Previous | Next »

Similar news on "Pancreatic cancer vaccine halts progression of disease in some patients":

1. Jefferson scientists show gene reverts cancer genes to normal, predicts breast cancer prognosis
   10-31-2006 · EurekAlert!
   Scientists have shown that the activity of a gene that commandeers other cancer-causing genes, returning them to normal, can predict the prognosis of an individual with breast cancer. They looked at cancer cells from more than 2,000 breast cancer patients and found that this commandeering or "organizing" ability is increasingly lost in cancer cells and associated with the progression of disease. The more the gene is expressed in breast cancer, the better the patient did.
   Similar news · Read more »
   
2. Chemotherapy with gemcitabine delays progression of operable pancreatic cancer
   09-27-2007 · EurekAlert!
   Giving pancreatic cancer patients the chemotherapy drug gemcitabine after surgery delays progression of the disease by about six months, according to new research by Japanese scientists.
   Similar news · Read more »
   
3. Drug that interrupts a key stage of cell division shows promise for advanced solid tumors
   11-08-2006 · EurekAlert!
   One of the first studies to investigate the effects of a new anti-cancer drug in patients with advanced or metastatic solid tumours has shown that it is capable of halting progression of the disease, and the study has provided the first proof of the drug's mechanism of action, the 18th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics in Prague was told on Wednesday.
   Similar news · Read more »
   
4. New tumour markers -- 'Spot the differences'
   06-20-2007 · EurekAlert!
   Pancreatic cancer (PC), the subject of this thesis, has the poorest prognosis of all cancers: the survival rate after five years with the disease is less than five percent and on average, patients who have been diagnosed with it do not live longer than six months.
   Similar news · Read more »
   
5. Gleevec, the targeted cancer pill, delivers more good news to patients
   12-09-2007 · EurekAlert!
   Gleevec, the targeted cancer pill that has saved more than 100,000 lives, now is saving more children with a dire leukemia, as well as preventing disease progression with long term use in adults with chronic myeloid leukemia.
   Similar news · Read more »
   
6. Mouse Tests Predict Drug Response In Relapsing Pancreatic Cancer Patients
   10-12-2006 · ScienceDaily
   By slicing up bits of patient tumors and grafting them into mice, Johns Hopkins Kimmel Cancer Center specialists have figured out how to accurately 'test drive' chemotherapy drugs to learn in advance which drug treatments offer each individual pancreatic cancer patient the best therapeutic journey.
   Similar news · Read more »
   
7. OHSU surgeon gives patients with lethal cancer reason to hope
   11-30-2006 · EurekAlert!
   Researchers in the OHSU Digestive Health Center are developing a system through which clinicians hope to more easily identify people at increased risk for the disease. Early identification allows physicians to identify malignancies sooner and begin aggressive treatment quicker. Only patients at high risk for pancreatic cancer will be monitored.
   Similar news · Read more »
   
8. New vaccine stimulates colorectal cancer patient's immune systems to fight cancerous cells
   11-15-2006 · EurekAlert!
   British researchers have developed a vaccine that stimulates colorectal cancer patients' immune systems to fight cancerous cells.
   Similar news · Read more »
   
9. Interferon does not slow or stop hepatitis C from worsening, study finds
   11-08-2007 · EurekAlert!
   Interferon does not slow or halt the progression of chronic hepatitis C and advanced liver disease in patients who haven't responded to previous attempts to eradicate the disease, a national study has found. Patients who were treated with interferon did experience a significant decrease in viral levels and liver inflammation, but the trial unequivocally demonstrated that treatment with interferon does not prevent the worsening of liver disease in patients who've failed prior treatments.
   Similar news · Read more »
   
10. Analysis of breast-cancer gene role offers promising target for drugs to stop or slow progression of disease
    10-30-2006 · UT Southwestern Medical Center
    Researchers at UT Southwestern Medical Center have for the first time described how multiple copies of a gene are responsible for metastases in early-stage breast cancer and poor prognosis for patients.
    Similar news · Read more »